Ernexa Therapeutics Inc.
ERNAW· Nasdaq
Released Mar 28, 2013, after the close
10-K filed Mar 29, 2013, 88 days after period end · 0001019687-13-001065
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $5.93M | $6.10M | — |
| Net Income | $629.00K | -$1.04M | — |
| EPS Diluted | $0.01 | -$0.02 |
Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.